← Back to Clinical Trials
Recruiting NCT06664177
NCT06664177 Analgesic Efficacy of Quadratus Lumborum vs. Transversalis Fascia Block in Inguinal Hernia Surgery
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT06664177 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gaziosmanpasa Research and Education Hospital |
| Condition | Pain, Postoperative |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2026-06-01 |
Trial Parameters
Condition Pain, Postoperative
Sponsor Gaziosmanpasa Research and Education Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 18 Years
Max Age 65 Years
Start Date 2024-11-01
Completion 2026-06-01
Interventions
Transversalis Fascia Plane BlockAnterior Quadratus Lumborum Block (QLB)
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
It is planned to compare the postoperative analgesic efficacy of the Transversalis Fascia Plane Block and the anterior Quadratus Lumborum Block in elective inguinal hernia surgeries.
Eligibility Criteria
Inclusion Criteria: * Ages 18-65 * ASA Classification 1-2 Exclusion Criteria: * Allergy to local anesthetics * Presence of infection at the procedure site * BMI \> 35 kg/m² * Bleeding disorders or anticoagulant use * Chronic analgesic or opioid use * Mental or psychiatric disorders * ASA Classification 3-4 patients(Severe COPD, history of cerebrovascular events, liver and kidney disease will be excluded from the study.)
Related Trials
NCT06917300
Virtual Reality as a Digital Premed to Alleviate Pain and Anxiety Preoperatively in Patients Undergo
View Trial →
NCT05917262
Comparing Mindfulness-based Breath Training and Heart Rate Variability Biofeedback for Shoulder Surg
View Trial →
NCT03715517
Spinal Anesthesia For Enhanced Recovery After Liver Surgery
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology